Public filings / GPCR on Yahoo Finance (opens in a new tab)
GPCR: insider buying, 13F holders, analyst moves
Structure Therapeutics Inc - US ADR
A summary of public filings about Structure Therapeutics Inc - US ADR. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
6 of our 100 managers hold GPCR
Combined reported value $830.6M; 1 sold out since Q1 2026.
Holders among our 100 managers: 3 in Q3 2023, 6 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors | $351.8M | 3.16% | Unchanged |
| Deep Track Capital | $254.4M | 3.75% | Added |
| RTW Investments | $86.3M | 0.74% | New |
| Baker Bros. Advisors | $76.9M | 0.39% | Unchanged |
| Deerfield Company | $58.3M | 0.61% | Added |
| Tudor Investment | $2.9M | 0.01% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.